Calidi Biotherapeutics, Inc. financial statements
Calidi Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 19.91M | 10-K |
| Cash and equivalents | USD 5.6M | 10-Q |
| Total debt | USD 600K | 10-Q |
Calidi Biotherapeutics, Inc. financials on 6ix · Calidi Biotherapeutics, Inc. on 6ix